Use of chemotherapy in elderly patients with early-stage triple-negative breast cancer

Lancet Oncol. 2020 Dec;21(12):1543-1545. doi: 10.1016/S1470-2045(20)30694-X.

Authors

Giuseppe Curigliano¹, Gabriella Pravettoni²

Affiliations

¹ European Institute of Oncology, IRCCS, Milan, Italy; Department of Oncology and Haemato-Oncology, University of Milan, 435 - Milan, Italy. Electronic address: giuseppe.curigliano@ieo.it.
² European Institute of Oncology, IRCCS, Milan, Italy; Department of Oncology and Haemato-Oncology, University of Milan, 435 - Milan, Italy.

PMID: 33271084
DOI: 10.1016/S1470-2045(20)30694-X

No abstract available

Publication types

Comment

MeSH terms

Aged
Breast Neoplasms* / drug therapy
Chemotherapy, Adjuvant
Female
Humans
Neoadjuvant Therapy
Triple Negative Breast Neoplasms* / drug therapy
Women*